ArticleJAC-antimicrobial resistance2025
National consumption of antimicrobials in Tanzania: 2020-2022.
Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- National and Hospital Level Antimicrobial Consumption Patterns in Kenya.Antibiotics (Basel, Switzerland) · 2026Article
- Evolutionary inference reveals global natural histories and predicted pathways of antimicrobial resistance in Klebsiella pneumoniae.PLoS biology · 2026Article
- Geospatial analysis of regional variations in antibiotic consumption in Tanzania from 2020 to 2024 using the electronic logistics management information system.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026Article
- Article
- Antimicrobial Consumption and Utilisation in Zambia: Results from the Analysis of National Data for the Human and Animal Health Sectors.Antibiotics (Basel, Switzerland) · 2025Article
- Emergence of carbapenem-producing enterobacteriaceae (CPE) and other multidrug-resistant gram-negative bacteria in neonates at a tertiary-level NICU in Tanzania: a point prevalence study.JAC-antimicrobial resistance · 2025Article
- Assessment of antimicrobial use and stewardship practices among animal health practitioners, veterinary drug retailers and cattle keepers in Mvomero, Tanzania.Frontiers in antibiotics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Global Leaders Group on Antimicrobial Resistance (AMR) beckoned nations to share surveillance data on antimicrobial consumption (AMC) and AMR while promoting access to essential antimicrobials in countries with the highest burden of AMR. Objectives: To analyse findings of the national-level AMC (years 2020-2022), building on our prior work (2017-2019), and to assess any emerging trends. Methods: Data were obtained from the Tanzania Medicines and Medical Devices Authority, Tanzania Medical Stores Department, and from local manufacturers. Results: The average defined daily dose (DDD) per 1000 inhabitants (DID) was 38.27 ± 5.17. Compared to 2020, macrolides had a nearly 3-fold increase in 2021 and 2022 driven by azithromycin (4.85 ± 2.85 DID), mainly associated with inappropriate use during the COVID-19 pandemic. In 2020, private-sector consumption accounted for 75.73% of the total, which increased to 84.02% in 2021 and then slightly decreased to 66.82% in 2022. The Access category antimicrobials met the World Health Organization target of 60% national consumption, while the Watch category has shown a steady increase in 2021 and 2022. Conclusion: The continued increase in AMC in the private sector calls for urgent antimicrobial stewardship targets, including routine reporting by the Access, Watch and Reserve categories.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.